Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Wegovy and Ozempic: could the new weight-loss drug also treat dementia?
General Research
22 May 2023
Brain and mental health innovation at Oxford
General Innovation Research
22 May 2023
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.
How mental health treatments are being extended with virtual reality
General Innovation Research
22 May 2023
Nearly one billion people worldwide suffer from some form of mental disorder, according to UN data, but relatively few can access the treatment they need. Innovative AI based therapy, developed by researchers at Oxford, is now enabling a greater number of people to get help.
The safety of GP prescribing in England was not adversely affected by the Covid-19 pandemic
Coronavirus COVID-19 General Research
19 May 2023
Researchers from the universities of Oxford and Nottingham have found that despite substantial disruption to primary care services, the safety of GP prescribing in England was largely unaffected by the Covid-19 pandemic.
Information day held for patients on WINGMEN trial
General Public Engagement with Research Research
16 May 2023
On Thursday 4 May, the Nuffield Department of Surgical Sciences (NDS) hosted a special information day for patients with prostate cancer participating in the WINGMEN clinical trial.
Ethnic minority patients yearn for warmth from health care professionals, research finds
General Research
12 May 2023
Developing better connections between ethnic minority patients and health care professionals could deliver more positive health care experiences for ethnic minority patients, according to a new study. The results have been published in PLOS ONE.
The best drugs for stopping smoking that you probably can’t have – new review
General Research
10 May 2023
When so much time and effort goes into developing the best medical treatments, we expect them to be available when we need them. The same goes for addiction treatments, so it’s worrying that two of the most effective drugs for quitting smoking aren’t available in the UK.
The Howat Foundation to fund Chair in Clinical Oncology
General Research
10 May 2023
Oxford Cancer is pleased to announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation.
Autoimmune disorders found to affect around one in ten people
General Research
9 May 2023
A new population-based study of 22 million people shows that autoimmune disorders now affect about one in ten individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences for several autoimmune disorders and provides new clues on possible causes behind these diseases.
DARWIN EU® success leads to expansion
General Research
3 May 2023
The European Medicines Agency (EMA) initiative DARWIN EU® has completed its first studies and is calling for new data partners
Oxford researchers discover why multisensory learning is beneficial for memory
General Research
26 April 2023
New research published in Nature, led by Department of Physiology, Anatomy & Genetics researchers Dr Zeynep Okray, Dr Pedro Jacob and Professor Scott Waddell, has discovered a detailed neural circuit mechanism that explains how multisensory learning improves memory performance.
Study shows need for greater screening for frailty in emergency hospital admissions
General Research
26 April 2023
A new study has shown the need for more widespread screening for frailty in unplanned admissions to hospitals to better inform the care received by patients.
The impact of childhood and teenage anxiety disorders on later life – new research
General Research
26 April 2023
New research has found that the consequences of anxiety disorders in young people can include mental health issues in adulthood, lower grades at school and lower earnings.
Feasibility study reviews the use of HRT for post-menopausal women with hand osteoarthritis
General Research
21 April 2023
A recent study to test the feasibility of running a randomised controlled trial of hormone replacement therapy (HRT) for post-menopausal women with hand osteoarthritis, has produced positive results. The HOPE-e feasibility study paves the way for researchers to design a full trial.
Elephant seals drift off to sleep while diving far below the ocean surface
General Research
21 April 2023
A new analysis of elephant seal brainwave patterns has revealed that these mammals take short naps while holding their breath on deep dives, averaging just 2 hours of sleep per day during their long trips at sea. The findings have been published today in the journal Science.
Twenty-five years of functional MRI of the brain at Oxford
Events General Research
21 April 2023
If you think back to 1998, you might remember it as the year that Google came into existence, or the year that construction began on the International Space Station, or perhaps even the year that the UK won the Eurovision Song Contest. But it was also a very significant year for medical sciences: the year that the Oxford Centre for Functional MRI of the Brain (FMRIB) officially opened.
Landmark antibody study to test immune responses against COVID-19
Coronavirus COVID-19 General Research
17 April 2023
Thousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination.
Trial investigating potential treatment for fatigue relief in people with long COVID reports results
Coronavirus COVID-19 General Research
17 April 2023
Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue. The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
Why focusing on COVID deaths undercounts the health harms of the pandemic
General Research
14 April 2023
While we have estimates of how many people have died from COVID globally (which currently run at just under 7 million), its broader effects – including mental health deterioration due, for example, to the anxiety of getting infected or the isolation of lockdowns – have received less research attention.
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana
General Research
14 April 2023
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority.